[caption id="" align="alignnone" width="800"] The delegation meeting with the Honorable Zhu Chen & Wei He[/caption] The National Foundation for Cancer Research (NFCR) has been promoting and facilitating collaboration among scientists from different countries, yet another role played by the organization in its efforts to help defeat...
https://youtu.be/S4bAu0i9i4w The National Foundation for Cancer Research’s (NFCR) annual marquee event was held in Washington, DC on Saturday evening, May 5th. The 2018 Szent-Györgyi Prize for Progress in Cancer Research ceremony and dinner occasioned much, including a gathering of NFCR principals and scientists, communication of the...
FOR IMMEDIATE RELEASE: May 16, 2018 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Three Articles Offer Possible Bases for Brain Cancer Treatments, Insight into Somatic Mutations ROCKVILLE, MD – A trio of papers co-authored by four National...
In a press release from Massachusetts General Hospital titled, “Glioma subtypes determine how the dangerous brain tumors spread, evade anti-angiogenic treatment” the research of NFCR Fellow, Rakesh Jain, Ph.D. is highlighted as published online in Cancer Cell in April, 2018. The study describes, “how different molecular subtypes of...
[caption id="attachment_20540" align="alignnone" width="1000"] NFCR Fellows Rakesh Jain, Alice Shaw and Danny Welch are among the speakers at the 2018 American Association for Cancer Research’s annual meeting[/caption] The National Foundation for Cancer Research’s (NFCR) presence is considerable at the 109th annual meeting of the American Association...
FOR IMMEDIATE RELEASE: April 5, 2018 CONTACT: Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Honor Recognizes Top Academic Inventors [caption id="attachment_20473" align="alignleft" width="300"] Rakesh K. Jain, Ph.D. and Paul B. Fisher, M.Ph, Ph.D.[/caption] BETHESDA, MD - In an event this afternoon at the historic...
President Bill Clinton declared March Colorectal Cancer Awareness Month in 2000, highlighting a disease that represents eight percent of all new cancers diagnosed yearly and, out of the estimated 135,430 people who developed it just last year, caused an estimated 50,260 deaths in the United...
FOR IMMEDIATE RELEASE: February 15, 2018 CONTACT: Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org First Occasion for Award to Recognize Extraordinary Contributions in Cancer Prevention, Role of Vaccines BETHESDA, MD - The National Foundation for Cancer Research (NFCR) announced today that the 2018 Szent-Györgyi Prize for Progress...
In the past two months, the FDA has approved a revolutionary new form of immunotherapy, called chimeric antigen receptor (CAR) T cell therapy, for two blood cancers: B cell acute lymphoblastic leukemia (ALL) in August, 2017 and now on October 18th, for aggressive diffuse large...
Szent-Györgyi Prize Winners: Then & Now The Szent-Györgyi Prize was established in honor of Nobel laureate Dr. Albert Szent-Györgyi, co-founder of NFCR, to recognize outstanding scientific achievement in the war against cancer. Ten years later, “ASG Winners: Then & Now” looks at these winners, their extraordinary contributions and how their discoveries...
Search NFCR
Popular searches